Brad is a biopharmaceutical and managed care leader with 27 years of experience and is currently Director of Government Accounts at Global Blood Therapeutics. Previously, he was a National Account Executive with Actelion Pharmaceuticals, a Janssen Pharmaceutical Company of Johnson & Johnson, and was responsible for FFS Medicaid, VA/DoD, as well as several commercial/Med D account relationships. Prior to Actelion, Brad worked at both large and small companies, including GSK and InterMune. During that time, he earned positions of increasing responsibility within sales and market access opportunities.
Burris received his BSBA from Appalachian State University and MBA/MHA degrees from Pfeiffer University. He is married (to a pharmacist) and enjoys spending time with family. While golf and travel are high on the list of priorities, most of their time away from work is spent with two energetic sons in the Raleigh, N.C. area.
Learn more about the our Crossroads 2020 Speakers!
As a reporter who didn't start covering pharma until 2016, I really appreciated this great roundup of important drug approvals of last decade, from @adamfeuerstein n @matthewherper